Endocan as a prognostic biomarker of triple-negative breast cancer

PURPOSE: Triple-negative breast cancer (TNBC) has aggressive characteristics and fewer treatment options than other subtypes. The purpose of this study was to explore prognostic biomarkers for TNBC that can be easily detected from the blood samples. METHODS: MDA-MB-231 and MDA-MB-231BR, a brain meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagara, Atsunobu, Igarashi, Katsuhide, Otsuka, Maky, Kodama, Akihiro, Yamashita, Mutsumi, Sugiura, Rei, Karasawa, Takeshi, Arakawa, Kazuhiko, Narita, Michiko, Kuzumaki, Naoko, Narita, Minoru, Kato, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225208/
https://www.ncbi.nlm.nih.gov/pubmed/27888420
http://dx.doi.org/10.1007/s10549-016-4057-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225208/
https://www.ncbi.nlm.nih.gov/pubmed/27888420
http://dx.doi.org/10.1007/s10549-016-4057-8

Ejemplares similares